Immunochemical faecal occult blood tests in primary care and the risk of delay in the diagnosis of colorectal cancer

Scandinavian Journal of Primary Health Care

Volumn 31, Issue 4, 2013, Pages 209-214

  Högberg, Cecilia ^a   Karling, Pontus ^a   Rutegård, Jörgen ^a   Lilja, Mikael ^a   Ljung, Thomas ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b MID SWEDEN UNIVERSITY   (Sweden)

Author keywords

Colorectal neoplasms; Diagnosis; General practice; Occult blood; Signs and symptoms; Sweden

Indexed keywords

ADENOMA; ADULT; AGED; CANCER GRADING; COLORECTAL NEOPLASMS; DELAYED DIAGNOSIS; FEMALE; HUMAN; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; OCCULT BLOOD; PATHOLOGY; PRIMARY HEALTH CARE; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; SWEDEN; VERY ELDERLY; ARTICLE; COLORECTAL TUMOR; METHODOLOGY; STATISTICS;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DELAYED DIAGNOSIS; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; OCCULT BLOOD; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SWEDEN;

EID: 84890066687     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.3109/02813432.2013.850205     Document Type: Article

References (27)

1. GLOBOCAN 2008. Available at: http://globocan.iarc.fr (accessed 8 February 2013).
2. Cancer incidence in Sweden 2011. National Board of Health and Welfare Available at: http://www.socialstyrelsen.se (accessed 8 February 2013).
3. Toll AD, Fabius D, Hyslop T, Pequignot E, DiMarino AJ, Infantolino A, et al. Prognostic significance of high-grade dysplasia in colorectal adenomas. Colorectal Dis 2010;13: 370-3.
4. Mansson J, Bjorkelund C, Hultborn R. Symptom pattern and diagnostic work-up of malignancy at first symptom presentation as related to level of care: A retrospective study from the primary health care centre area of Kungsbacka, Sweden. Neoplasma 1999;46:93-9. (Pubitemid 29317905)
5. Carlsson L, Hakansson A, Nordenskjold B. Common cancer-related symptoms among GP patients: Opportunistic screening in primary health care. Scand J Prim Health Care 2001;19:199-203. (Pubitemid 32963962)
6. Vandvik PO, Kristensen P, Aabakken L, Farup PG. Abdominal complaints in general practice: Diagnoses and characteristics of patients. Scand J Prim Health Care 2004;22:157-62. (Pubitemid 39281028)
7. Svendsen RP, Stovring H, Hansen BL, Kragstrup J, Sonder-gaard J, Jarbol DE. Prevalence of cancer alarm symptoms: Apopulation-based cross-sectional study. Scand J Prim Health Care 2010;28:132-7.
8. Astin M, Griffin T, Neal RD, Rose P, Hamilton W. The diagnostic value of symptoms for colorectal cancer in primary care: A systematic review. Br J Gen Pract 2011;61:e231-43.
9. Thompson MR, Perera R, Senapati A, Dodds S. Predictive value of common symptom combinations in diagnosing colorectal cancer. Br J Surg 2007;94:1260-5. (Pubitemid 47584776)
10. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71. (Pubitemid 23131388)
11. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, BalfourTW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7. (Pubitemid 26400242)
12. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71. (Pubitemid 26400241)
13. Zorzi M, Fedato C, Grazzini G, Stocco FC, Banovich F, Bortoli A, et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 2011;60:944-9.
14. Zhu MM, Xu XT, Nie F,Tong JL, Xiao SD, Ran ZH. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: A meta-analysis. J Dig Dis 2010;1 1:148-60.
15. Rozen P, Comaneshter D, Levi Z, Hazazi R, Vilkin A, Maoz E, et al. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use. Cancer 2010;116:2115-25.
16. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. Luxembourg: Publications Office of the European Union; 2011. Available at: http:// bookshop. europa.eu.
17. Jellema P, van derWindt DAWM, Bruinvels DJ, Mallen CD, vanWeyenberg SJB, Mulder CJ, et al. Value of symptoms and additional diagnostic tests for colorectal cancer in primarycare: Systematic review and meta-analysis. BMJ 2010;340: c1269-c.
18. Gillberg A, Ericsson E, Granstrom F, Olsson LI. A population-based audit of the clinical use of faecal occult blood testing in primary care for colorectal cancer. Colorectal Dis 2012;14:e539-46.
19. Högberg C, Asplund R. Många feces-Hb-test till liten nytta. Immunkemisk metod ger dålig diagnoshjälp, visar primärvå rdsstudie (Small benefit of many feces-Hb tests. Low diagnostic value of the immunochemical method according to a primary health care study). English summary. Lakartidningen 2010;107:1372-5.
20. Regionalt cancercentrum norr. Available at: http://www. cancercentrum.se/norr/.
21. Obtained from Oy Medix Biochemica Ab. Available at: http:// www.medixbiochemica.com.
22. NICE clinical guidelines. Referral guidelines for suspected cancer. Available at: http://publications.nice.org.uk (accessed 8 February 2013).
23. McDonald PJ, Digby J, Innes C, Strachan JA, Carey FA, Steele RJ, et al. Low faecal haemoglobin concentration potentially rules out significant colorectal disease. Colorectal Dis2013;15:el51-9.
24. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsene D, Boutreux S, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007;56:210-14.
25. Trickett JP, Donaldson DR, Bearn PE, Scott HJ, Hassall AC. A study on the routes of referral for patients with colorectal cancer and its effect on the time to surgery and pathological stage. Colorectal Dis 2004;6:428-31. (Pubitemid 39529890)
26. Barrett J, Jiwa M, Rose P, Hamilton W. Pathways to the diagnosis of colorectal cancer: An observational study in three UK cities. Fam Pract 2006;23:15-9.
27. Barlow L,Westergren K, Holmberg L,Talback M.The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol 2009;48:27-33.